Obinutuzumab, a B-cell depleting therapy, is being explored for reducing lupus nephritis risks, such as flare.

The FDA is allowing Sarepta to resume shipments of Elevidys (delandistrogene moxeparvovec) to ambulatory patients with Duchenne muscular dystrophy.

The Mediterranean, AHEI, and DASH dietary patterns were linked to reduced risk of type 2 diabetes across ethnic groups.

Maria J. Monroy-Iglesias, Ph.D., from King’s College London, and colleagues used data from the U.K. biobank (151,543 individuals with at least one serum vitamin D level measurement at baseline, 2006 ...

HealthDay News — Women with multiple sclerosis (MS) are less likely to receive disease-modifying therapies (DMTs) than men, according to a study published online July 30 in Neurology.

Children with higher polygenic scores showed accelerated body mass index gain from age 2.5 years to adolescence.